Register Now: From Clinical to Commercial: Accelerating ADC Late-Stage Development with Technology Innovation and Integrated Platform
|Articles|February 1, 2017

Visit Bio-Rad at Interphex 2017

Bio-Rad has supplied solutions to life science and clinical diagnostic researchers for over 60 years.

Bio-Rad has supplied solutions to life science and clinical diagnostic researchers for over 60 years. These solutions support scientists across Drug Discovery & Development. With customizable solutions that work better together, learn how our Workflow Revolution is creating research workflows that enable you to get to market faster with the right molecule while reducing downtime, error and waste.

Related to this article

The BioPharm Brief: FDA’s Fast-Track Pilot Reportedly Stalls, a Long-Acting Bispecific for Atopic Dermatitis, and a Twice-Yearly Obesity Approach
FDA has reportedly shelved its Commissioner’s National Priority Voucher pilot and paused publishing complete response letters, Zai Lab’s IL-13/IL-31Rα bispecific ZL-1503 shows a 40- to 50-day half-life that points to dosing every 12 weeks, and Wave Life Sciences reports 1-year INLIGHT data for its INHBE-silencing siRNA WVE-007 in obesity.